Concepedia

Author

Ali M. Harandi

University of Gothenburg

Also Known As

A. M. Harandi, A.M. Harandi, ALI M. HARANDI, Ali HARANDI, Ali Harandi, Ali M Harandi, Ali M. Harandi, Asgharzadeh, Mahdi, Claire-Anne Siegrist, Gianni Pozzi

111

Publications

3.2K

Citations

31

H-Index

90

Concepts

All Affiliations

University of GothenburgBC Children's HospitalUniversity of British ColumbiaUniversity of SienaToscana Life Sciences
AM

About

Ali M. Harandi is an author at University of Gothenburg specializing in medicine, immunology, and vaccination.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

26

1.3K

2

Allergy

4

4

259

3

Engineering

3

3

118

4

Health Sciences

1

1

11

5

Public Health

1

1

50

Ali M. Harandi

×

46

Publications

2.3K

Citations

25

H-Index

YearCitations

Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens

Frank Wegmann, Kate H. Gartlan, Ali M. Harandi,

Nature Biotechnology

2012

231

Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens

Niels Peter Hell Knudsen, Anja Weinreich Olsen, Cecilia Buonsanti,

Scientific Reports

2016

229

A Protective Role of Locally Administered Immunostimulatory CpG Oligodeoxynucleotide in a Mouse Model of Genital Herpes Infection

Ali M. Harandi, Kristina Eriksson, Jan Holmgren

Journal of Virology

2002

162

Differential roles of B cells and IFN-γ-secreting CD4+ T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice

Ali M. Harandi, Bo Svennerholm, Jan Holmgren,

Journal of General Virology

2001

128

Single-cell BCR and transcriptome analysis after influenza infection reveals spatiotemporal dynamics of antigen-specific B cells

Nimitha R. Mathew, Jayalal K. Jayanthan, Jonathan L. Robinson,

Cell Reports

2021

117

Vaccine adjuvants: A priority for vaccine research

Ali M. Harandi, Donata Medaglini, Robin J. Shattock

Vaccine

2010

91

Interleukin-12 (IL-12) and IL-18 Are Important in Innate Defense against Genital Herpes Simplex Virus Type 2 Infection in Mice but Are Not Required for the Development of Acquired Gamma Interferon-Mediated Protective Immunity

Ali M. Harandi, Bo Svennerholm, Jan Holmgren,

Journal of Virology

2001

89

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study

Angela Huttner, Sélidji Todagbé Agnandji, Christophe Combescure,

The Lancet Infectious Diseases

2018

79

The Mucosal Adjuvant Effect of α-Galactosylceramide for Induction of Protective Immunity to Sexually Transmitted Viral Infection

Madelene Lindqvist, Josefine Persson, Karolina Thörn,

The Journal of Immunology

2009

76

Mucosal Administration of CpG Oligodeoxynucleotide Elicits Strong CC and CXC Chemokine Responses in the Vagina and Serves as a Potent Th1-Tilting Adjuvant for Recombinant gD2 Protein Vaccination against Genital Herpes

Sara Tengvall, Annika Lundqvist, Roselyn J. Eisenberg,

Journal of Virology

2006

72

Page 1